Page 167 - Color Atlas of Biochemistry
P. 167

158       Metabolism



             Regulation                                          Glucocorticoids—mainly     cortisol   (see
                                                              p. 374)—induceall of thekey enzymes in-
                                                              volved in gluconeogenesis [4,6,8,9]. At the
             A. Regulation of carbohydrate metabolism
                                                              same time, they also induce enzymes in-
             In all organisms, carbohydrate metabolism is     volved in amino acid degradation and thereby
             subject to complex regulatory mechanisms         provide precursors for gluconeogenesis. Reg-
             involving    hormones,     metabolites,   and    ulation of the expression of PEP carboxy-
             coenzymes. The scheme shown here (still a        kinase, a key enzyme in gluconeogenesis, is
             simplified one) applies to the liver, which      discussed in detail on p. 244.
             has central functions in carbohydrate metab-        Metabolites. High concentrations of ATP
             olism (see p. 306). Some of the control mech-    and citrate inhibit glycolysis by allosteric reg-
             anisms shown hereare noteffectivein other        ulation of phosphofructokinase. ATP also
             tissues.                                         inhibits pyruvate kinase. Acetyl-CoA, an inhib-
                One of the liver’smost important tasksisto    itor of pyruvate kinase, has a similar effect. All
             store excess glucose in the form of glycogen     of these metabolites arise from glucose
             and to release glucose from glycogen when        degradation (feedback inhibition). AMP and
             required (buffer function). When the glycogen    ADP, signals for ATP deficiency, activate gly-
             reserves are exhausted, the liver can provide    cogen degradation and inhibit gluconeogene-
             glucose by de novo synthesis (gluconeogene-      sis.
             sis; see p. 154). In addition, like all tissues, the
             liver breaks glucose down via glycolysis.
             These functions have to be coordinated with      B. Fructose 2,6-bisphosphate
             each other. For example, there is no point in    Fructose 2,6-bisphosphate (Fru-2,6-bP) plays
             glycolysis and gluconeogenesis taking place      an important part in carbohydrate metabo-
             simultaneously, and glycogen synthesis and       lism. Thismetabolite isformed in small quan-
             glycogen degradation should not occur simul-     tities from fructose 6-phosphate and has
             taneously either. This is ensured by the fact    purely regulatory functions. It stimulates gly-
             that two different enzymes exist for important   colysis by allosteric activation of phospho-
             steps in both pathways, each of which cata-      fructokinase and inhibits gluconeogenesis by
             lyzes only the anabolic or the catabolic reac-   inhibition of fructose 1,6-bisphosphatase.
             tion. The enzymes are also regulated differ-        The synthesis and degradation of Fru-2,6-
             ently. Only these key enzymes are shown          bP are catalyzed by one and the same protein
             here.                                            [10a, 10b]. If the enzyme is present in an un-
                Hormones. The hormones that influence         phosphorylated form [10a], it acts as a kinase
             carbohydrate metabolism include the pepti-       and leads to the formation of Fru-2,6-bP. After
             des insulin and glucagon; a glucocorticoid,      phosphorylation by cAMP-dependent protein
             cortisol; and a catecholamine, epinephrine       kinase A (PK-A), it acts as a phosphatase [10b]
             (see   p. 380).  Insulin  activates  glycogen    and now catalyzes the degradation of Fru-2,6-
             synthase ([1]; see p. 388), and induces several  bP to fructose 6-phosphate. The equilibrium
             enzymes involved in glycolysis [3, 5, 7]. At the  between [10a] and [10b] is regulated by hor-
             same time, insulin inhibits the synthesis of     mones. Epinephrine and glucagon increase
             enzymes     involved    in   gluconeogenesis     the cAMP level (see p. 120). As a result of
             (repression; [4,6,8,9]). Glucagon, the antag-    increased PK-A activity, this reduces the Fru-
             onist of insulin, has the opposite effect. It    2,6-bP concentration and inhibits glycolysis,
             induces gluconeogenesis enzymes [4, 6, 8, 9]     while at the same time activating gluconeo-
             and represses pyruvate kinase [7], a key en-     genesis. Conversely, via [10a], insulin acti-
             zyme of glycolysis. Additional effects of glu-   vates the synthesis of Fru-2,6-bP and thus
             cagonare based onthe interconversion of en-      glycolysis. In addition, insulin also inhibits
             zymes and are mediated by the second mes-        the action of glucagon by reducing the cAMP
             senger cAMP. This inhibits glycogen synthesis    level (see p. 120).
             [1]   and    activates   glycogenolysis   [2].
             Epinephrine acts in a similar fashion. The in-
             hibition of pyruvate kinase [7] by glucagon is
             also due to interconversion.


           Koolman, Color Atlas of Biochemistry, 2nd edition © 2005 Thieme
           All rights reserved. Usage subject to terms and conditions of license.
   162   163   164   165   166   167   168   169   170   171   172